The Broadcom Sell-Off: Why This Is a Huge Warning Flag for Artificial Intelligence (AI) Investors

Broadcom reported Q2 revenue of $22.19 billion, up 48% year over year, but missed consensus of $22.27 billion and did not raise full-year guidance. Adjusted EPS of $2.44 beat the $2.40 estimate, yet the lack of a beat-and-raise quarter disappointed investors given the stock's roughly 100x trailing earnings valuation. Shares fell as much as 16% intraday, highlighting the market's sensitivity to AI-linked growth expectations and premium multiples.

Analysis

The market reaction is less about one marginal miss and more about the fragility of the AI premium when growth is already capitalized into the multiple. AVGO has become a consensus expression of “AI infrastructure upside,” so any sign that management is pacing guidance rather than pulling demand forward forces investors to question whether the next leg of returns is fundamentally driven or just multiple expansion. That matters because at this valuation band, the stock needs sustained revision momentum; stable guidance is effectively a negative surprise.

Second-order, the read-through is not that AI demand is weakening, but that the beneficiaries are likely to rotate down the stack. If custom accelerators face a digestion phase or a less linear booking curve, spend may migrate toward GPUs, networking, memory bandwidth, and power infrastructure where capacity constraints still allow pricing power. In that setup NVDA can stay comparatively insulated, while AVGO becomes the canary for how quickly hyperscaler capex gets translated into revenue recognition versus just pipeline growth.

The near-term risk is a de-rating cycle that lasts days to weeks, but the deeper risk is months-long multiple compression if “beat-and-raise” stops being the default assumption for AI leaders. The market is implicitly telling you it will pay for acceleration, not merely durability. If AVGO can re-accelerate orders or lift guidance on the next print, the stock can snap back hard; absent that, rallies should be sold into because the burden of proof has shifted materially higher.

Contrarian view: this is not a broken thesis, it is a broken setup. The underlying demand story may still be intact, but the stock is priced like a flawless compounder, so even small execution variance is enough to trigger air pockets. That creates a better entry window later, but only after the post-earnings volatility drains and the market re-prices AVGO closer to a growth-with-quality name rather than a no-error AI winner.

Key Decisions for Investors

• Reduce AVGO exposure on any intraday rebound over the next 1-5 trading days; use strength to cut risk until management re-accelerates guidance, because the stock is trading like a 100x multiple name that now needs surprise upside to justify it.
• Pair trade: long NVDA / short AVGO for the next 1-3 months. The relative trade benefits if AI capex remains strong but the market prefers the cleaner growth narrative and supply-constrained beneficiaries over guidance-sensitive infrastructure names.
• If you want optionality, buy AVGO put spreads 1-2 months out rather than outright puts; risk/reward is better because the thesis is multiple compression, not a collapse in fundamentals, and volatility should remain elevated after the print.
• Watch for a re-entry setup in AVGO only after a second confirming catalyst: either a guidance raise at the next event or evidence that custom AI chip revenue is converting into harder backlog. Until then, patience is the better trade.
• Consider a tactical long in the AI supply chain where pricing power is still underappreciated, especially names tied to networking, optics, or power, because the market may rotate away from the most crowded AI premium names first.